Skip to content

Bioenergetic Technology

Using Bioenergetic Technology to heal our bodies and minds

Menu

  • Home
  • About us
  • Contact us

Seahorse Bioscience – Growing in a World of Budget Constraints

Uncategorized chief, chief-executive, conference, discuss-the-factors, europe, factors, mass-, officer, seahorse, seahorse-bioscience, sept-, talk-at-europe, teich, the-factors

BILLERICA, Mass., Sept. 23, 2013 /PRNewswire/ — In an invited talk at Europe's 2013 MipTec Conference and Exhibition, Seahorse Bioscience Chief Executive Officer, Jay Teich, will discuss the factors that …

See the original post:
Seahorse Bioscience – Growing in a World of Budget Constraints

Related posts:

  1. Seahorse Bioscience and the Cancer Research UK Beatson Institute Team Up Against Cancer
  2. Seahorse Bioscience Inc. Announces Zhejiang University Graduate Biology Scholarship
  3. Seahorse Bioscience Announces AACR Travel Award Recipients
  4. Seahorse Bioscience and University of Alabama at Birmingham Partner to Advance Validation of Bioenergetic Health Index …
  • ← Seahorse Bioscience and the Cancer Research UK Beatson Institute Team Up Against Cancer
  • Cornerstone Pharmaceuticals Initiates Phase II Clinical Trial of CPI-613 for the Treatment of Myelodysplastic Syndrome →

Recent Posts

  • Reata gets FDA orphan drug status for bardoxolone methyl to treat PAH
  • New Subtle Energy Pattern Research Shows Increases in Cell Growth and Viability
  • Cornerstone Pharmaceuticals' CPI-613 Selected as One of Informa and Kantar Health 2014 Top 10 Most Interesting …
  • Cornerstone Pharmaceuticals Announces Positive Phase I Data for CPI-613 in Relapsed or Refractory AML Patients to be …
  • Cornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Hodgkin's or T-Cell Non …
Copyright © 2025 Bioenergetic Technology. All rights reserved.
Theme: Accelerate by ThemeGrill. Powered by WordPress.